Business August 8, 2020
Takeda loses battle to stop Mylan from selling generic gout drug
Takeda Pharmaceuticals (NYSE: TAK) failed to stop Mylan (NASDAQ: MYL) from selling a generic version of its Colcrys, a treatment…
Business August 8, 2020
Takeda Pharmaceuticals (NYSE: TAK) failed to stop Mylan (NASDAQ: MYL) from selling a generic version of its Colcrys, a treatment…
By Marivic Cabural Summers
Investigates November 8, 2017
While Oklahomans will head to the poll in November 2018 to vote on whether marijuana should be legal for medicinal…
By Robin Bull

